Profile
| Metric | Value |
|---|---|
| Full Name | Vaxart, Inc. |
| Ticker | NASDAQ: VXRT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | vaxart.com |
| Employees | 105 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.68 | |
| Price, 1D Change | +41.67% | |
| $163M | ||
| - | ||
| - | ||
| 0.93 | ||
| $29M | ||
| Revenue, 1Y Change | +288.94% | |
| -$0.33 | ||
| EPS, 1Y Change | +41.83% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $12.19 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:11 | |
| Next Split | N/A | N/A |
| Last Ticker Change | AVIR | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.33 | ||
| EPS Estimate | -$0.29 | |
| EPS Est. Change | +12.44% | |
| $28.70M | ||
| Revenue Estimate | $202.70M | |
| Revenue Est. Change | +606.27% | |
| Current Price | $0.68 | |
| Price Target | - | $4.00 |
| Price Tgt. Change | - | +488.24% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.61 | -$0.57 | +6.66% | |
| -$0.40 | -$0.33 | +17.20% | |
| -$0.29 | N/A | +12.44% | |
| -$0.34 | N/A | -2.66% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.10M | $7.38M | +138.03% | |
| $34.30M | $28.70M | -16.33% | |
| $202.70M | N/A | +606.27% | |
| $110.33M | N/A | +284.44% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.68 | |
| $0.40 | ||
| SMA 200 vs Price | -41.84% | |
| $0.38 | ||
| SMA 50 vs Price | -44.76% | |
| 0.93 | ||
| $0.04 | ||
| 90.94 | ||
| 207.40% | ||
| 110.24% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $12.19 | |
| Upcoming | N/A | N/A |
| - | ||
| Total Dividend | - | |
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $28.70M | ||
| -$0.33 | ||
| $24.30M | ||
| 84.67% | ||
| -$66.29M | ||
| -230.99% | ||
| -$66.95M | ||
| -233.27% | ||
| -$61.89M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.40 | ||
| 0.75 | ||
| 0.75 | ||
| - | ||
| 4 | ||
| -4.40 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1.10 | ||
| 6.10 | ||
| -3.62 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $58.93M | ||
| $51.72M | ||
| $166.39M | ||
| $68.26M | ||
| $107.46M | ||
| $90.88M | ||
| $23.28M | ||
| $7.14M | ||
| $6.96M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $95.65M | ||
| $90.59M | ||
| $4.40M | ||
| $0.00 | ||
| $8.85M | ||
| $0.00 | ||
| $260.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$44.76M | ||
| -$21.32M | ||
| $56.56M | ||
| $554.00K | ||
| -$45.32M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| B. Riley Securities | → | |
| Oppenheimer | ||
| B. Riley Securities | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → | |
| B. Riley Securities | ||
| Cantor Fitzgerald | ||
| B. Riley Securities | ||
| Cantor Fitzgerald | ||
| B. Riley Securities | → |
Analyst sentiment
Institutional ownership
Screeners with VXRT
Data Sources & References
- VXRT Official Website vaxart.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/72444/000143774925034840/0001437749-25-034840-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/72444/000143774925008572/0001437749-25-008572-index.htm
- VXRT Profile on Yahoo Finance finance.yahoo.com/quote/VXRT
- VXRT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vxrt
FAQ
What is the ticker symbol for Vaxart, Inc.?
The ticker symbol for Vaxart, Inc. is NASDAQ:VXRT
Does Vaxart, Inc. pay dividends?
No, Vaxart, Inc. does not pay dividends
What sector is Vaxart, Inc. in?
Vaxart, Inc. is in the Healthcare sector
What industry is Vaxart, Inc. in?
Vaxart, Inc. is in the Biotechnology industry
What country is Vaxart, Inc. based in?
Vaxart, Inc. is headquartered in United States
When did Vaxart, Inc. go public?
Vaxart, Inc. initial public offering (IPO) was on December 11, 1981
Is Vaxart, Inc. in the S&P 500?
No, Vaxart, Inc. is not included in the S&P 500 index
Is Vaxart, Inc. in the NASDAQ 100?
No, Vaxart, Inc. is not included in the NASDAQ 100 index
Is Vaxart, Inc. in the Dow Jones?
No, Vaxart, Inc. is not included in the Dow Jones index
When was Vaxart, Inc. last earnings report?
Vaxart, Inc.'s most recent earnings report was on November 13, 2025
When does Vaxart, Inc. report earnings?
The next expected earnings date for Vaxart, Inc. is March 19, 2026